Alzai Health Corp. (TSXV: ALZI)
Health Care · Health Care Technology · CA
CA$0.30
-18.92% today · -28.6% 1Y
Alzai Health Corp. (TSXV: ALZI) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $13.64M.
Over the last twelve months the share price has lost 28.6%, trading between 0.28 and 0.50.
Tweenvest scores Alzai Health Corp. across four factors: quality 9/100, value 61/100. Its strongest factor is value.
ALZI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.64M
- Revenue (TTM)
- $49.25K
- P/E
- —
- EPS
- -0.08
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- CA$0.50
- 52-week low
- CA$0.28
- Avg volume (3M)
- —
- Shares outstanding
- 64.79M
- Employees
- —
- Next earnings
- —
About Alzai Health Corp.
Alzai Health Corp. develops a disease risk screening platform, enabling disease prevention and early disease diagnosis to improve patient outcomes. The company was founded by Hayim Raclaw, Roy Kait and Ofri Kait on November 15, 2024 and is headquartered in Toronto, Canada.
- ISIN
- CA02262P1036
- Founded
- 2024
- Listed since
- Jun 9, 2026
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Welby Inc.TSE: 4438 | $15.64M | ¥289.00 | +4.33% |
| iZafe Group AB (publ)OM: IZAFE B | $14.33M | Skr0.33 | +20.58% |
| PainChek LimitedASX: PCK | $14.02M | AU$0.10 | -0.52% |
| Intrasense S.A.ENXTPA: ALINS | $13.86M | €0.24 | -6.75% |
| Ortivus AB (publ)OM: ORTI B | $13.44M | Skr1.52 | -6.17% |
| ImExHS LimitedASX: IME | $12.42M | AU$0.33 | +3.17% |
| Vidavo S.A.ATSE: VIDAVO | $12.20M | €10.40 | -1.89% |
| MedApp S.A.WSE: MDA | $11.51M | zł0.17 | -5.03% |
Figures last refreshed Oct 4, 2026.